Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media
Open Access
- 18 March 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (4) , 865-869
- https://doi.org/10.1093/ndt/gfh039
Abstract
Background. Radiocontrast media (RCM) administration is a common cause of hospital-acquired acute renal failure, especially in high-risk patients, but mechanisms of nephrotoxicity have not been fully elucidated. Reactive oxidant species recently have been shown to play a role in experimental RCM nephropathy, while there is clinical evidence that acetylcysteine, an antioxidant drug, has a protective effect against RCM nephropathy in humans. However, no study has been published showing that RCM administration elicits oxidative stress in humans. Methods. In an unselected series of patients undergoing elective cardiac catheterization for coronary artery angiography and/or angioplasty, we monitored the time course of plasma and urinary levels of free 3-nitrotyrosine (3-NT), a stable marker of peroxynitrite generation resulting from the in vivo reaction of superoxide and nitric oxide. Urinary 3-NT levels were measured as the ratio of urinary 3-NT to urinary creatinine. Measurements were taken at baseline, immediately after the procedure and at 24, 48 and 72 h. Results. Twenty-six patients were studied (median age 67.5 years, range 42–86; baseline serum creatinine 1.0 mg/dl, 0.6–1.5; RCM dose 215 ml, 100–580). Plasma 3-NT levels slightly increased over the 72 h following the procedure (PPP = 0.017). Conclusions. The present study provides indirect evidence that RCM administration in humans is associated with an increased production of 3-NT. Further studies are needed to ascertain whether oxygen- and nitrogen-derived radical species play a major role in the pathogenesis of RCM-associated nephrotoxicity in the clinical setting.Keywords
This publication has 18 references indexed in Scilit:
- High Glucose-Induced Tyrosine Nitration in Endothelial Cells: Role of eNOS Uncoupling and Aldose Reductase ActivationInvestigative Opthalmology & Visual Science, 2003
- A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID studyJournal of the American College of Cardiology, 2003
- Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrastCatheterization and Cardiovascular Interventions, 2003
- Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and InterventionJAMA, 2003
- A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiographyKidney International, 2002
- Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast doseThe American Journal of Cardiology, 2002
- Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathyCatheterization and Cardiovascular Interventions, 2002
- Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by AcetylcysteineNew England Journal of Medicine, 2000
- Pathophysiology of Radiocontrast NephropathyInvestigative Radiology, 1999
- Osteoporosis in MenArchives of internal medicine (1960), 1998